PF-02413873

CAS No. 936345-35-6

PF-02413873( PF-2413873 )

Catalog No. M16701 CAS No. 936345-35-6

PF-02413873 (PF-2413873) is a potent, selective, fully competitive, and orally active progesterone receptor (PR) antagonist with Ki of 9.7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 Get Quote
5MG 72 Get Quote
10MG 115 Get Quote
25MG 237 Get Quote
50MG 380 Get Quote
100MG 565 Get Quote
500MG 1215 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PF-02413873
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-02413873 (PF-2413873) is a potent, selective, fully competitive, and orally active progesterone receptor (PR) antagonist with Ki of 9.7 nM.
  • Description
    PF-02413873 (PF-2413873) is a potent, selective, fully competitive, and orally active progesterone receptor (PR) antagonist with Ki of 9.7 nM; displays >30-fold selectivity over other homologous nuclear hormone receptors, GR, AR, and MR; blocks the follicular phase increase in endometrial thickness, the midcycle lutenizing hormone surge, and elevation in estradiol in a dose-dependent fashion compared with placebo in clinical trials.Other Indication Phase 1 Discontinued.
  • In Vitro
    PF-02413873 shows potent PR antagonist activity with a derived Ki of 9.7 nM in the T47D native functional assay.PF-02413873 (1 nM-10 μM) induces nuclear translocation only at high concentrations (>3 μM).
  • In Vivo
    PF-02413873 (2.5 and 10 mg/kg; p.o. twice daily for 10 days) induces a statistically significant reduction in endometrial thickness in cynomolgus macaques.PF-02413873 (3 mg/kg; a single p.o.) exhibits t1/2 (4.2 h), Cmax (162 ng/mL) and CL/F (41 mL/min/kg). Animal Model:Cynomolgus macaques (3.7-5.7 kg; 5-6 years)Dosage:2.5, 10 mg/kg Administration:P.o. twice daily for 10 days Result:Reduced the endometrial thickness of 43 and 56% at the dose of 2.5 and 10 mg/kg, respectively.Animal Model:Cynomolgus macaques (3.7-5.7 kg; 5-6 years)Dosage:3 mg/kg (Pharmacokinetic Analysis)Administration:A single p.o.Result:t1/2=4.2 h, Cmax=162 ng/mL, CL/F=41 mL/min/kg.
  • Synonyms
    PF-2413873
  • Pathway
    Nuclear Receptor/Transcription Factor
  • Target
    Progesterone Receptor
  • Recptor
    Progesterone Receptor
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    936345-35-6
  • Formula Weight
    359.44
  • Molecular Formula
    C18H21N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (278.21 mM)
  • SMILES
    N#CC1=C(C)C=C(OC2=C(C)N(CS(=O)(C)=O)N=C2C3CC3)C=C1C
  • Chemical Name
    4-((3-cyclopropyl-5-methyl-1-((methylsulfonyl)methyl)-1H-pyrazol-4-yl)oxy)-2,6-dimethylbenzonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bungay PJ, et al. Drug Metab Dispos. 2011 Aug;39(8):1396-405. 2. Howe DC, et al. J Pharmacol Exp Ther. 2011 Nov;339(2):642-53.
molnova catalog
related products
  • Nomegestrol acetate

    Nomegestrol acetate is a widely used progestin-like drugwhich is characterized as a full agonist at the progesterone receptor.

  • Nomegestrol

    Nomegestrol (TX 066 free base) is an orally available, selective and potent full agonist of the progesterone receptor with potent anti-estrogenic, partial anti-androgenic and anti-gonadotropic activity.

  • Melengestrol acetate

    Melengestrol acetate is a derivative of progesterone and acts as a corticosteroid hormone. Melengestrol acetate promotes endometrial proliferation delay of menstrual activity and pregnancy maintenance.